# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-160519
Filing Date
2021-05-13
Accepted
2021-05-13 16:21:10
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d155579d10q.htm iXBRL | 10-Q | 1371259
2 | EX-31.1 | d155579dex311.htm | EX-31.1 | 6693
3 | EX-31.2 | d155579dex312.htm | EX-31.2 | 6687
4 | EX-32.1 | d155579dex321.htm | EX-32.1 | 6352
10 | GRAPHIC | g155579g25t34.jpg | GRAPHIC | 162570
| Complete submission text file | 0001193125-21-160519.txt |  | 4664559

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | sbtx-20210331.xsd | EX-101.SCH | 31898
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | sbtx-20210331_cal.xml | EX-101.CAL | 25820
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | sbtx-20210331_def.xml | EX-101.DEF | 114770
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | sbtx-20210331_lab.xml | EX-101.LAB | 264105
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | sbtx-20210331_pre.xml | EX-101.PRE | 214850
11 | EXTRACTED XBRL INSTANCE DOCUMENT | d155579d10q_htm.xml | XML | 461424

Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39756 | Film No.: 21919954
SIC: 2834 Pharmaceutical Preparations